Article Details
Retrieved on: 2024-03-28 20:14:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
ArriVent BioPharma, Inc. Company progresses the development of furmonertinib with a data readout planned for 2024. Furmonertinib granted Breakthrough ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here